graves'%20disease
GRAVES' DISEASE
Graves' disease is an autoimmune disorder that results into overproduction of thyroid hormones.
Thyrotoxicosis signs and symptoms include hyperactivity, irritability, insomnia, dysphoria, sweating, heat intolerance, palpitations, weakness, fatigue, weight loss despite increased appetite, diarrhea, steatorrhea polyuria, decreased libido, tachycardia, tremor, goiter, alopecia, gynecomastia, eyelid lag or retraction and rarely periodic paralysis.
Clinical features in thyrotoxic patient that suggests Graves's disease are ophthalmopathy, thyroid dermopathy, thyroid acropachy, diffuse goiter, antibodies to thyroid peroxidase or thyroglobulin and thyroid radionuclide scan demonstrating a diffuse goiter.

Graves' Disease Drug Information

Drug Information

Indication: Management of HTN, angina pectoris, cardiac arrhythmias, MI.

Indication: HTN; angina pectoris; MI. Disturbances of cardiac rhythm including supraventricular tachycardia. Functional he...

Indication: RA, acute gouty arthritis, bronchial asthma, serum sickness, lupus, nodular arthritis, allergic dermatitis, pe...

Indication: Adjuvant of maintenance therapy & short-term administration in psoriatic arthritis, ankylosing spondylitis...

Indication: Control of HTN; cardiac arrhythmias; anxiety & anxiety tachycardia. Management of angina pectoris; essenti...

Indication: Severe hypersensitivity & dermatological reaction; severe acute & chronic inflammatory & allergic ...

Indication: Hyperthyroidism. Prep for thyroidectomy in hyperthyroidism. Therapy prior to & post radio-iodine treatment...

Indication: HTN, angina pectoris, acute MI.

Dosage: HTN 100-400 mg as single or bd dose. Angina pectoris 50-100 mg bd-tds. Cardiac arrhythmias 50 mg bd-tds up to

1  /  5
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
24 Nov 2020
Undergoing in-facility physical activity (PA) programmes initiated before the 20th week of gestation helps reduce the risk of developing gestational diabetes mellitus (GDM) among high-risk mothers, according to the results of a meta-analysis.